Bg pattern

VOXZOGO 0.56 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use VOXZOGO 0.56 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Voxzogo 0.4 mg powder and solvent for solution for injection

Voxzogo 0.56 mg powder and solvent for solution for injection

Voxzogo 1.2 mg powder and solvent for solution for injection

vosoritide

This medicinal product is subject to additional monitoring, which will allow for the quick identification of new safety information. You can help by reporting any side effects you may have to your doctor. The last section of section 4 will tell you how to report side effects.

Read all of this leaflet carefully before you start using this medicine, because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you or your child have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you or your child only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you or your child get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Voxzogo and what is it used for
  2. What you need to know before you use Voxzogo
  3. How to use Voxzogo
  4. Possible side effects
  5. Storage of Voxzogo
  6. Contents of the pack and other information

1. What is Voxzogo and what is it used for

What is Voxzogo

Voxzogo contains the active substance vosoritide. It is similar to a protein found in the body called C-type natriuretic peptide (CNP). Vosoritide is made using recombinant technology, where bacteria are modified to include the gene that produces the protein.

What Voxzogo is used for

This medicine is used to treat achondroplasia in patients aged 4 months and older whose bones are still growing. Achondroplasia is a genetic disorder that affects the growth of almost all the bones in the body, including the bones of the skull, spine, arms, and legs, resulting in a greatly reduced height with a characteristic appearance.

This product is only indicated for achondroplasia caused by a mutation in the FGFR3 gene, confirmed by genetic testing.

How Voxzogo works

The active substance in Voxzogo works directly on the growth plates of the bones to promote the growth of new bone.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Voxzogo

Do not use Voxzogo

  • if you or your child are allergic to vosoritide or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor before starting Voxzogo:

  • if you or your child have significant heart or blood pressure problems;
  • if you or your child are taking or have recently taken medicines to lower blood pressure.

If any of the above applies to you or your child, or if you are not sure, talk to your doctor before using Voxzogo.

Effects on blood pressure

Voxzogo may lower blood pressure. As a result, you may feel dizzy, tired, or nauseous. Blood pressure usually returns to normal within 90 minutes after the Voxzogo injection. If these effects occur and are severe, tell your doctor.

Drinking plenty of fluids at the time of injection may reduce the likelihood of these effects. Patients are recommended to eat a snack and drink enough fluid (such as water, milk, or juice) about 30 minutes before the injection.

Children and adolescents

There is not enough information on the use of this medicine in children under 4 months, and therefore, its use is not recommended.

Other medicines and Voxzogo

Tell your doctor if you or your child are taking, have recently taken, or might take any other medicines.

Pregnancy and breastfeeding

If you or your daughter are receiving treatment with this medicine and you or your daughter are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.

The use of this medicine is not recommended during pregnancy and breastfeeding.

Driving, cycling, and using machines

This medicine may make you feel dizzy, tired, or nauseous for a few minutes after the injection. In this case, do not drive, cycle, engage in physical activities, or use machines for about 1 hour after the injection or until you feel better.

Voxzogo contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per dose; this is essentially "sodium-free".

3. How to use Voxzogo

The Voxzogo injection should be given by a caregiver. Do not inject Voxzogo into your child until you have received the necessary training from a healthcare professional.

Follow the instructions for administering this medicine exactly as told by your doctor. If you are unsure, consult your doctor or pharmacist again.

Dose

Your doctor will choose the correct dose based on your or your child's body weight. The doctor will tell you how much solution for injection to inject. If you are unsure, consult your doctor or pharmacist.

Table 1 shows the dose that you or your child will need to inject daily based on body weight. The amount to inject will be presented in different volumes depending on the type of syringe included in the pack (milliliters (ml) or units (U)). Check that you have the correct dose for the syringe you are using.

Table 1: Single-dose volumes by body weight in ml and unit volumes (U)

Weight

(kg)

Dose (mg)

Vosoritide 0.4 mg

solvent (water for

injectable preparations):

0.5 ml concentration:

0.8 mg/ml

Vosoritide 0.56 mg

solvent (water for

injectable preparations):

0.7 ml concentration:

0.8 mg/ml

Vosoritide 1.2 mg

solvent (water for

injectable preparations):

0.6 ml concentration:

2 mg/ml

Daily injection volume

ml

Units

ml

Units

ml

Units

4

0.12 mg

0.15 ml

15 U

5

0.16 mg

0.20 ml

20 U

6-7

0.20 mg

0.25 ml

25 U

8-11

0.24 mg

0.30 ml

30 U

12-16

0.28 mg

0.35 ml

35 U

17-21

0.32 mg

0.40 ml

40 U

22-32

0.40 mg

0.50 ml

50 U

33-43

0.50 mg

0.25 ml

25 U

44-59

0.60 mg

0.30 ml

30 U

60-89

0.70 mg

0.35 ml

35 U

≥ 90

0.80 mg

0.40 ml

40 U

You or your child should eat a snack and drink enough water, milk, or juice about 30 minutes before receiving the injection. This may reduce side effects such as dizziness, tiredness, or nausea.

How to use Voxzogo

Inject Voxzogo slowly under the skin (subcutaneous injection).

The injection should be given at about the same time every day.

It is recommended to inject at a different site each day and not to use the same site 2 days in a row. Do not inject the medicine into areas with moles, scars, or birthmarks, or into areas where the skin is sensitive, bruised, red, or hard.

If you use more Voxzogo than you should

If you inject more Voxzogo than you should, contact your doctor immediately.

If you forget to use Voxzogo

If your child misses a dose, they should be given the injection if it is not more than 12 hours since the scheduled time. If more than 12 hours have passed since the scheduled time, the missed dose should not be given. Wait until the next day and continue with the usual dose at the usual time.

If you stop using Voxzogo

Before deciding to stop your child's treatment, always consult your child's doctor. If you or your child have any further questions on the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Very common side effects

May affect more than 1 in 10 people:

  • Vomiting
  • Low blood pressure (temporary effects include dizziness, tiredness, or nausea shortly after receiving the injection)
  • Injection site reactions: redness, itching, inflammation, swelling, bruising, rash, hives, pain. Injection site reactions are usually mild and resolve on their own within a few hours.
  • High levels of alkaline phosphatase in the blood (shown in blood tests)

Common side effects

May affect up to 1 in 10 people:

  • Nausea
  • Feeling of dizziness and loss of consciousness
  • Dizziness
  • Tiredness

Reporting of side effects

If you or your child experience any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Voxzogo

Keep this medicine out of the sight and reach of children.

Do notuse this medicine after the expiry date which is stated on the carton after "EXP". The expiry date is the last day of the month shown.

Store in a refrigerator (between 2°C and 8°C). Do not freeze.Keep the pack in the outer carton in order to protect from light.

Voxzogo may be stored at room temperature (below 30°C) for up to 90 days, but not after the expiry date. Do notreturn Voxzogo to the refrigerator after it has been stored at room temperature. Writethe date on the carton when you remove Voxzogo from the refrigerator to store at room temperature.

Use Voxzogo as soon as it is prepared as a solution. In any case, it must be administered within 3 hours of preparation. Do not use this medicine if the solution for injection is cloudy or contains particles.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Container Contents and Additional Information

Voxzogo Composition

  • The active ingredient is vosoritide.
  • Each 0.4 mg vial of reconstituted powder in a 0.5 ml solvent solution corresponds to a concentration of 0.8 mg/ml.
  • Each 0.56 mg vial of reconstituted powder in a 0.7 ml solvent solution corresponds to a concentration of 0.8 mg/ml.
  • Each 1.2 mg vial of reconstituted powder in a 0.6 ml solvent solution corresponds to a concentration of 2 mg/ml.
  • The other components are citric acid (E 330), sodium citrate (E 331), trehalose dihydrate, mannitol (E 421), methionine, and polysorbate 80 (E 433).
  • The solvent is water for injectable preparations.

Appearance of Voxzogo and Container Contents

Voxzogo powder and solvent for injectable solution are supplied as:

  • a powder for injectable solution that is white to yellow in color in a glass vial and
  • a clear and colorless solvent (water for injectable preparations) to dissolve the powder.

After dissolving the powder in the solvent, the solution is a clear liquid, colorless to yellow.

Each box contains:

  • 10 Voxzogo vials
  • 10 pre-filled syringes with water for injectable preparations
  • 10 single-use needles
  • 10 single-use syringes

Marketing Authorization Holder and Manufacturer

BioMarin International Limited

Shanbally, Ringaskiddy

County Cork

Ireland

P43 R298

Date of Last Revision of this Leaflet: MM/YYYY.

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu. There are also links to other websites on rare diseases and orphan medicines.

Instructions for Use of the Graduated Syringe in Milliliters (ml)

Read these instructions for use before using Voxzogo and every time you perform a refill. There may be new information.

Supplied Elements for Injecting Voxzogo (see Figure A)

Figure A

Voxzogo Vial

Solvent Needle

(the blue tab retracts the needle)

Solvent Syringe(contains water for

injectable preparations for the

reconstitution of Voxzogo)

Vial of medicine with liquid and gray cap next to a circular filter with dotted edge

Syringe with needle inserted into a blue rubber stopper showing cylinder filling

Pre-filled transparent syringe with gray plunger and long, thin metal needle

Injectable Syringe

Pre-filled transparent syringe with visible plunger and white end cap showing numerical graduations

Consult your doctor or healthcare professional if you are unsure of the recommended dose or how to use the solvent needle and injectable syringe.

Necessary Elements Not Supplied in the Container (see Figure B)

If you do not have these elements, consult your pharmacist.

Figure B

Alcohol-impregnated wipes

Sharps container

Gauze or dressings

White box with rounded corners and thin lines marking a central empty area

Biological waste container with black infectious hazard symbol on white background and gray border

Folded white gauze pad next to a rectangular gray adhesive strip with dotted texture

PREPARATION FOR INJECTION

Before starting, make sure the work surface is clean and that you have washed your hands.

Step 1:On a clean and flat surface, remove

the closure cap from the vial and clean the

top with an alcohol wipe.

Do not touch the vial stopper with your fingers after

cleaning it with the alcohol wipe.

Hand removing the protective cap from a medicine vial with a gray and circular safety device

Step 2:Gently tilt the solvent syringe to

remove the cap.

Two fingers holding an injection device with a transparent needle and a rotary button with an arrow indicating rotation

Step 3:Screw the solvent needle onto the

solvent syringe until it can no longer be

turned.

Hand holding a syringe with a connected needle and another without a needle, arrow indicates connection direction, blue liquid inside

Step 4:Remove the needle cap and insert

the needle into the vial through the middle

of the stopper. Slowly push the syringe

plunger to inject all the liquid.

Be careful not to push the blue tab until step 5.

Auto-injector device with needle inserted into skin showing direction arrows and mechanism parts

Step 5:Remove the needle from the vial and

then press the blue tab to retract the

needle. Discard the needle and syringe in

a sharps container. See step 19 and “How to

discard (dispose of) Voxzogo”.

Do not use the solvent syringe to administer the

injection.

CAUTION: Be careful not to touch the needle tip.

Hand holding syringe with needle inserted into vial and another hand holding vial cap, arrow indicates direction

Auto-injector device with blue cartridge and visible needle being pressed by a finger

Step 6:Gently shake the vial in a circular

motion until the powder is completely

dissolved and the solution is clear.

Do not shake the vial.

Make sure the medicine has a color of clear to

yellow and is not cloudy or contains particles.

Hand holding medicine vials rotating in a counter-clockwise direction, arrow indicates movement

Step 7:Remove the needle cap from the

injectable syringe and insert the needle

into the vial in a straight line through the

middle of the stopper.

Be careful not to bend the needle.

CAUTION: Do not replace the needle cap.

Syringe with needle inserted into a medicine vial and another syringe ready to use with arrows indicating direction

Step 8:Carefully hold the vial and syringe and

invert the vial with the needle still

inserted. The vial should be on top.

Be careful not to bend the needle.

Hand holding syringe with needle inserted vertically into a transparent vial with liquid inside

Step 9:Keep the needle tip in the medicine and

slowly pull the syringe plunger back to

withdraw the prescribed dose into the

syringe.

Check the prescription label for the amount to

withdraw.

CAUTION: Withdraw the prescribed dose.

Hand holding syringe with needle pointing downwards and inserted into skin with arrow indicating injection direction

Step 10:Gently tap the syringe with a finger to

remove large air bubbles. Then, slowly

push the bubbles back into the vial.

Hand holding syringe with needle inserted into skin, black arrow indicates extraction direction and graduated cylinder visible

Step 11:Repeat steps 9 and 10 until you have the

correct prescribed dose in the syringe and

there are no large bubbles.

Make sure the dose in the syringe matches the

prescribed dose. Measure from the base of the

plunger, as shown in the figure.

CAUTION: Remove large bubbles.

It is acceptable to have 1 or 2 small bubbles.

Syringe needle with plunger showing measurement on a graduated scale from 0.2 to 0.7 with arrow indicating 0.6

Step 12:Make sure you have the prescribed dose

in the syringe and then remove the vial and

prepare to administer the dose.

CAUTION:Before removing the vial, check that

the amount matches the prescribed dose.

Hand holding vial and another hand with syringe withdrawing medicine with needle pointing upwards

SELECTION AND PREPARATION OF THE INJECTION SITE

Step 13:Voxzogo should be injected into the fat layer under the skin (subcutaneous layer) only.

  • Do not inject through clothing.
  • Do not inject into the same area twice in a row.
  • Do not inject into painful, bruised, red, hard, or scarred skin

It is recommended to use the following areas for injections:

  • back of the upper armsor
  • thighsor
  • abdomen(5 centimeters from the navel) or
  • buttocks

Two human figures showing shaded areas on buttocks, thighs, and abdomen indicating intramuscular injection sites

Step 14:Clean the injection site with an alcohol wipe and let the skin dry.

Do not touch the injection site again before administering the injection.

Hand applying a transdermal patch to light gray skin with the index finger pressing

ADMINISTRATION OF THE VOXZOGO INJECTION

Step 15:After cleaning the area with an

alcohol wipe, pinch the skin upwards around

the chosen injection site.

Hand holding syringe with needle inserted into skin showing correct angle and injection position

Step 16:Quickly insert the entire needle into

the skin at a 45-degree angle.

Hand holding syringe with 45-degree angle inserting needle into skin showing shaded area and angle measurement

Step 17:Release the pinch and slowly push the

syringe plunger all the way in. Inject the full

dose.

Hand holding a pen injector with needle inserted into skin showing a dotted circle at the injection site

Step 18:Continue pressing the plunger until

the needle retracts into the syringe.

Hand holding an auto-injector with arrows indicating pressure and release, showing the needle inserted into the skin

Step 19:Discard the vial, syringes, and needles

used in a sharps container. See “How to

discard (dispose of) Voxzogo” for more

information.

Syringe with needle, medicine vial, and biological waste container with biohazard symbol, arrow indicates disposal

AFTER INJECTING VOXZOGO

  • Check the injection site. If you see a small amount of blood at the injection site, press gently with a gauze for a few seconds or apply a dressing.
  • Do notrub the injection site.
  • Be aware of signs of low blood pressure, such as dizziness, fatigue, or feeling unwell. If you have these symptoms, call your doctor or healthcare professional and then lie down on your back and put pillows under your legs to keep them elevated.

HOW TO DISCARD (DISPOSE OF) VOXZOGO

Place used or expired vials, needles, and syringes in a sharps container immediately after use.

If you do not have a sharps container, you can use a household container that:

  • is made of heavy-duty plastic;
  • can be closed with a tight-fitting, puncture-resistant lid that prevents sharps from coming out;
  • is kept upright and stable during use;
  • is leak-resistant and
  • is properly labeled to warn of hazardous waste.

When the container you use for disposing of sharps is almost full, you must follow local guidelines for disposing of it properly.

Medicines, vials, loose needles, and syringes should not be thrown away in the trash. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

INSTRUCTIONS FOR USE OF THE GRADUATED SYRINGE IN UNITS (U)

The solvent needles and administration syringes included in this package are new components marked with “Units” (U) to measure the recommended dose. Your doctor will indicate the recommended dose to administer based on your weight interval.

Supplied Elements for Injecting Voxzogo (see Figure A)

Figure A

Voxzogo Vial

Solvent Needle

Solvent Syringe(contains water for

injectable preparations for the reconstitution

of Voxzogo)

Vial with liquid and gray cap next to a plunger inside a syringe outlined with dashed lines

Schematic view of an auto-injection device with inserted cartridge and visible push button

Pre-filled transparent syringe with gray plunger and long, thin metal needle

Injectable Syringe

Transparent syringe with numerical scale from 10 to 90 units, black plunger, and chromed metal connectors

Your dose can be administered using the injectable syringe in Figure A. The measurements for this syringe are equivalent to ml as follows: 0.1 ml = 10 units.

Necessary Elements Not Supplied in the Container (see Figure B)

If you do not have these elements, consult your pharmacist.

Figure B

Alcohol-impregnated wipes

Sharps container

Gauze or dressings

Concentric white squares with rounded corners and thin lines indicating depth

Gray container with white circle showing a syringe and needle inside and text indicating sharps below

Folded white gauze pad next to a rectangular gray adhesive strip with texture

PREPARATION FOR INJECTION

Before starting, make sure the work surface is clean and that you have washed your hands.

Step 1:On a clean and flat surface, remove

the closure cap from the vial and clean the

top with an alcohol wipe.

Do not touch the vial stopper with your fingers after

cleaning it with the alcohol wipe.

Hand removing the protective cap from a medicine vial with a gray safety device

Step 2:Gently tilt the solvent syringe to

remove the cap.

Two fingers holding an injection device with a transparent needle and a rotary button with an arrow indicating rotation

Step 3:Screw the solvent needle onto the

solvent syringe until it can no longer be

turned.

Hand holding a syringe with a connected needle and another hand screwing an adapter onto another syringe with liquid and arrow indicating direction

Step 4:Remove the needle cap and insert

the needle into the vial through the middle

of the stopper. Slowly push the syringe

plunger to inject all the liquid.

Auto-injector device with exposed needle pressing against skin with hand holding the device

Step 5:Remove the needle from the vial. Discard

the needle and syringe in a sharps container.

See step 18 and “How to discard (dispose of)

Voxzogo”.

Do not use the solvent syringe to administer the

injection.

CAUTION: Be careful not to touch the needle tip.

Hand holding an injection device with needle inserted into vial and arrows indicating usage direction

Step 6:Gently shake the vial in a circular

motion until the powder is completely

dissolved and the solution is clear.

Do not shake the vial.

Make sure the medicine has a color of clear to

yellow and is not cloudy or contains particles.

Hand holding medicine vials rotating in a counter-clockwise direction, arrow indicates movement

Vial of transparent medication held between fingers with a circular arrow indicating rotation to mix the contents

Step 7:Remove the cap from the syringe needle and

insert the needle into the vial in a straight line through

the middle of the stopper.

Be careful not to bend the needle.

WARNING: Do not put the cap back on the needle.

Syringe extracting liquid from a vial with the hand holding and black arrows indicating direction of movement

Step 8:Carefully hold the vial and the syringe and

invert the vial with the needle still inserted. The vial

should be on top.

Be careful not to bend the needle.

Hands holding a syringe with a connected needle extracting liquid from a transparent vial with a gray stopper

Step 9:Keep the tip of the needle in the

medication and, slowly, pull the plunger back to

extract the prescribed dose into the syringe.

Check the prescription label for the

amount to be extracted.

WARNING: Verify the syringe

supplied in the packaging and extract the prescribed dose.

Hand holding a syringe with a needle inserted into the skin showing direction of advancement with a black arrow

Step 10:Gently tap the syringe with a finger to eliminate large air bubbles. Then, slowly push the

bubbles back into the vial.

Hand holding an auto-injector with a black arrow indicating the direction of pressure on the top button

Step 11:Repeat steps 9 and 10 until you have the correct prescribed dose in the syringe and there are no large bubbles.

Make sure the dose in the syringe matches the prescribed dose. Measure from the base of the plunger, as shown in the figure.

WARNING: Eliminate large bubbles.It is acceptable to have 1 or 2 small bubbles.

Transparent syringe with a numerical scale from 10 to 80 units, arrows indicating direction, and a dotted circle over the liquid

Step 12:Ensure you have the prescribed dose in the syringe and then remove the vial and prepare to administer the dose.

WARNING:Before removing the vial, check that the amount matches the prescribed dose.

Hand holding a syringe extracting medication from a transparent vial with a needle inserted and an arrow indicating direction

SELECTION AND PREPARATION OF THE INJECTION SITE

Step 13:Voxzogo should be injected into the fat layer under the skin (subcutaneous layer)

only.

  • Do not inject through clothing.
  • Do not inject into the same area twice in a row.
  • Do not inject into painful, bruised, red, hard, or scarred skin

The following areas are recommended for injections:

  • the back of the upper armsor
  • thighsor
  • abdomen(5 centimeters from the navel) or
  • buttocks

Two human figures showing shaded areas on buttocks, thighs, and abdomen indicating intramuscular injection sites

Step 14:Clean the injection site with an

alcohol swab and let the skin dry on its own.

Do not touch the area again before administering

the injection.

Hand applying a transdermal patch to the skin, showing the adhesive layer and the gray application area

ADMINISTRATION OF THE VOXZOGO INJECTION

Step 15:After cleaning the area with an

alcohol swab, pinch the skin upward around the

chosen injection site.

Hand holding an applicator device with the button pressed and inserting a fine needle into the skin

Step 16:Quickly insert the entire needle into

the skin at a 45-degree angle.

Hand holding a syringe with a needle inserted into the skin at 45 degrees, arrow indicates direction of injection, shaded angle

Step 17:Stop pinching and, slowly, push the

syringe plunger all the way down. Inject the full dose.

Hand holding an auto-injector with the needle inserted into the skin, showing a dotted circle at the injection site

Step 18:Discard the vial, syringes, and needles

used in a sharps container. See “How to dispose of (discard)

Voxzogo” for more information.

Biological waste container with hazard symbol, needleless syringe, adapter, and visible needle

AFTER INJECTING VOXZOGO

  • Check the injection site. If you see a small amount of blood at the injection site, gently press with a gauze for a few seconds or apply a bandage.
  • Do notrub the injection site.
  • Be aware of signs of low blood pressure, such as dizziness, fatigue, or feeling unwell. If you have these symptoms, call your doctor or healthcare professional and then lie down on your back and place pillows under your legs to keep them elevated.

HOW TO DISPOSE OF (DISCARD) VOXZOGO

Place used or expired vials, needles, and syringes in a sharps container immediately after use.

If you do not have a sharps container, you can use a household container that:

  • is made of heavy-duty plastic;
  • can be closed with a tight-fitting, puncture-resistant lid that prevents the sharps from coming out;
  • is kept upright and stable during use;
  • is leak-resistant and
  • is properly labeled to warn that it contains hazardous waste.

When the container you use to discard sharps is almost full, you should follow local guidelines for proper disposal.

Medications, vials, loose needles, and syringes should not be thrown away in the trash. Ask your pharmacist how to dispose of containers and medications you no longer need. This will help protect the environment.

Online doctors for VOXZOGO 0.56 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Discuss questions about VOXZOGO 0.56 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for VOXZOGO 0.56 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION?
VOXZOGO 0.56 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in VOXZOGO 0.56 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION?
The active ingredient in VOXZOGO 0.56 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION is vosoritide. This information helps identify medicines with the same composition but different brand names.
Who manufactures VOXZOGO 0.56 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION?
VOXZOGO 0.56 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION is manufactured by Biomarin International Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of VOXZOGO 0.56 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether VOXZOGO 0.56 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to VOXZOGO 0.56 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION?
Other medicines with the same active substance (vosoritide) include VOXZOGO 0.4 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION, VOXZOGO 1.2 mg POWDER AND SOLVENT FOR INJECTABLE SOLUTION, BOMYNTRA 120 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media